Molecular Breast Imaging (MBI)-Guided Biopsy

NANot yet recruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

June 30, 2027

Primary Completion Date

February 29, 2028

Study Completion Date

June 30, 2028

Conditions
Breast Cancer DetectionBreast NeoplasmMolecular ImagingBiopsyDense Breasts
Interventions
DEVICE

Molecular Breast Imaging

MBI is a molecular imaging (nuclear medicine) technique using a low dose i.v. radiopharmaceutical injection and solid-state gamma cameras to image the breast, where cancer mitochondria avidly take up the radiopharmaceutical.

DEVICE

MBI-guided biopsy

Two stereotactic MBI views of the breast produce a precise 3D location for each lesion targeted for biopsy. A vacuum-assisted core biopsy needle is guided to the lesion position.

Trial Locations (1)

75390

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

University of Texas, Southwestern Medical Center at Dallas

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Smart Breast Corp.

INDUSTRY